Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Efficacy and Safety of Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in High-Risk Patients.
Miglionico M, Mangiacapra F, Nusca A, Scordino D, Gallo P, Campanale M, Melfi R, Di Sciascio G. Miglionico M, et al. Am J Cardiol. 2015 Dec 1;116(11):1690-4. doi: 10.1016/j.amjcard.2015.08.041. Epub 2015 Sep 10. Am J Cardiol. 2015. PMID: 26428021
The efficacy and safety of drug-coated balloon (DCB) in patients with high-risk clinical features are largely unknown. We enrolled 82 consecutive patients at high risk of bleeding with angiographically significant (di …
The efficacy and safety of drug-coated balloon (DCB) in patients with high-risk clinical features …
Evaluation of paclitaxel-coated balloon angioplasty for the treatment of symptomatic intracranial in-stent restenosis.
Xue H, Xi J, Wu XF, Feng S, Wang J, Chen L. Xue H, et al. Front Neurol. 2024 May 22;15:1360609. doi: 10.3389/fneur.2024.1360609. eCollection 2024. Front Neurol. 2024. PMID: 38841701 Free PMC article.
BACKGROUND: Symptomatic intracranial in-stent restenosis (sISR) poses a major challenge in the management of cerebrovascular diseases, often requiring effective and safe treatment options. OBJECTIVES: This study aims to evaluate the efficacy and …
BACKGROUND: Symptomatic intracranial in-stent restenosis (sISR) poses a major challenge in the management of cerebrovas …